Date published: 2025-12-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

VEGF-B Activators

VEGF-B Activators belong to a specialized class of chemical compounds designed to modulate the activity of vascular endothelial growth factor B (VEGF-B). VEGF-B is a member of the vascular endothelial growth factor (VEGF) family, a group of signaling proteins that play essential roles in angiogenesis, the process of blood vessel formation. Unlike some other VEGF family members that are well-known for their roles in promoting angiogenesis, VEGF-B has distinct functions and is primarily associated with regulating vascular stability and metabolic homeostasis. VEGF-B is produced as a proprotein that undergoes proteolytic cleavage to generate bioactive forms.

VEGF-B Activators are compounds designed to specifically interact with VEGF-B and influence its signaling pathways. These activators can modulate VEGF-B activity either by enhancing or inhibiting its effects, depending on their chemical structure and mode of action. By targeting VEGF-B, these compounds have the ability to affect processes related to vascular biology, such as vessel permeability and maintenance. Although VEGF-B's precise mechanisms and functions are still being elucidated, it has been suggested to have a role in cardiac and skeletal muscle metabolism, making it an interesting subject for research in the context of cardiovascular and metabolic diseases. The study of VEGF-B Activators provides valuable insights into the intricate regulatory mechanisms of angiogenesis and vascular stability beyond the well-established functions of other VEGF family members. Researchers continue to explore the mechanisms of VEGF-B activation and its implications in various physiological processes to better understand its unique roles in vascular biology.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$118.00
$320.00
$622.00
$928.00
$1234.00
38
(1)

A PPARγ agonist that can enhance VEGF-B expression as part of its angiogenic and vasodilatory effects.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$54.00
$123.00
13
(1)

Another PPARγ agonist, known to upregulate VEGF-B expression, contributing to angiogenesis.

Fenofibrate

49562-28-9sc-204751
5 g
$40.00
9
(1)

Activates PPARα and may indirectly increase VEGF-B levels, influencing vascular growth.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$109.00
$350.00
8
(0)

Known for its anti-angiogenic properties, it can paradoxically upregulate VEGF-B under certain conditions.

β-Estradiol

50-28-2sc-204431
sc-204431A
500 mg
5 g
$62.00
$178.00
8
(1)

A form of estrogen that can increase VEGF-B expression, potentially influencing angiogenesis.

Vildagliptin

274901-16-5sc-208485
10 mg
$173.00
4
(1)

A DPP-4 inhibitor, shown to upregulate VEGF-B in certain contexts, affecting vascular dynamics.

β-Nicotinamide mononucleotide

1094-61-7sc-212376
sc-212376A
sc-212376B
sc-212376C
sc-212376D
25 mg
100 mg
1 g
2 g
5 g
$92.00
$269.00
$337.00
$510.00
$969.00
4
(1)

Involved in NAD+ biosynthesis, can indirectly affect VEGF-B levels through energy metabolism pathways.

hydroxychloroquine

118-42-3sc-507426
5 g
$56.00
1
(0)

Although primarily an antimalarial, it can affect VEGF-B expression in certain immunological contexts.